The therapeutic potential of the pharmacological inhibition of PBEF/NAMPT/Visfatin in inflammatory bowel disease

被引：0
|
作者：
Gerner, R. [1 ]
Wieser, V. [1 ]
Bichler, A. [1 ]
Moschen, A. [1 ]
Tilg, H. [1 ]
机构：
[1] Univ Innsbruck, Dept Internal Med 1, A-6020 Innsbruck, Austria
来源：
JOURNAL OF CROHNS & COLITIS | 2014年 / 8卷
关键词：
D O I：
10.1016/S1873-9946(14)60130-6
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P006
引用
收藏
页码：S67 / S67
页数：1
相关论文
共 50 条
  • [21] Therapeutic Potential to Modify the Mucus Barrier in Inflammatory Bowel Disease
    Sun, Jing
    Shen, Xiao
    Li, Yi
    Guo, Zhen
    Zhu, Weiming
    Zuo, Lugen
    Zhao, Jie
    Gu, Lili
    Gong, Jianfeng
    Li, Jieshou
    NUTRIENTS, 2016, 8 (01):
  • [22] TRP channels in inflammatory bowel disease: Potential therapeutic targets
    Du, Yaoyao
    Chen, Jie
    Shen, Lan
    Wang, Bing
    BIOCHEMICAL PHARMACOLOGY, 2022, 203
  • [23] The therapeutic potential of histamine receptor ligands in inflammatory bowel disease
    Neumann, Detlef
    Seifert, Roland
    BIOCHEMICAL PHARMACOLOGY, 2014, 91 (01) : 12 - 17
  • [24] The potential therapeutic role of vitamin D in inflammatory bowel disease
    Boccuzzi, L.
    Infante, M.
    Ricordi, C.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2023, 27 (10) : 4678 - 4687
  • [25] Pharmacological Control of Autophagy: Therapeutic Perspectives in Inflammatory Bowel Disease and Colorectal Cancer
    Garcia-Maurino, Sofia
    Alcaide, Antonio
    Dominguez, Cecilia
    CURRENT PHARMACEUTICAL DESIGN, 2012, 18 (26) : 3853 - 3873
  • [26] Therapeutic Potential of the Combination of Pentoxifylline and Vitamin-E in Inflammatory Bowel Disease: Inhibition of Intestinal Fibrosis
    Lee, Hyun Joo
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (16)
  • [27] Serum Visfatin as a Diagnostic Marker of Active Inflammatory Bowel Disease
    Saadoun, Mo'men M.
    Nosair, Nahla Abd El-Aziz
    Abdel-Azeez, Hala Abdel-Hameed
    Sharaf, Samar M.
    Ahmed, Mohammed Hussien
    JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2021, 30 (03) : 339 - 345
  • [28] Cathepsins B, L and D in inflammatory bowel disease macrophages and potential therapeutic effects of cathepsin inhibition in vivo
    Menzel, K.
    Hausmann, M.
    Obermeier, F.
    Schreiter, K.
    Dunger, N.
    Bataille, F.
    Falk, W.
    Scholmerich, J.
    Herfarth, H.
    Rogler, G.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2006, 146 (01): : 169 - 180
  • [29] Dysbiosis in Inflammatory Bowel Disease: Pathogenic Role and Potential Therapeutic Targets
    Santana, Patricia Teixeira
    Bittencourt Rosas, Siane Lopes
    Ribeiro, Beatriz Elias
    Marinho, Ygor
    de Souza, Heitor S. P.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (07)
  • [30] The potential therapeutic role of Lactobacillus reuteri for treatment of inflammatory bowel disease
    Wang, Huiyu
    Zhou, Chunli
    Huang, Junxiang
    Kuai, Xiaoyi
    Shao, Xinyu
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2020, 12 (05): : 1569 - 1583
12345